ESR1 and breast cancer: In breast cancer, a state of increased tissue inflammation with higher inflammatory infiltrates was observed and significantly associated with ER negative status [7, 8], while higher inflammation was associated with more aggressive tumor, poor response to endocrine therapy, and poor prognosis in ER positive breast cancer [9].